Search
Descriptor English: COVID-19
Descriptor Spanish: COVID-19
Descriptor COVID-19
Entry term(s) COVID19
brote de COVID-19
brote de la COVID-19
brote de neumonía de China de 2019-2020
brote del nuevo coronavirus de 2019
brote por 2019-nCoV
brote por el 2019-nCoV
brote por el coronavirus 2019-nCoV
brote por el coronavirus de Wuhan
brote por el coronavirus de Wuhan de 2019-2020
brote por el nuevo coronavirus (2019-nCoV)
brote por el nuevo coronavirus 2019
brote por el nuevo coronavirus de 2019
enfermedad del coronavirus de 2019
enfermedad del nuevo coronavirus de 2019
enfermedad por coronavirus 2019-nCoV
enfermedad por coronavirus de 2019
enfermedad por el 2019-nCoV
enfermedad por el coronavirus 2019-nCoV
enfermedad por el coronavirus de 2019
enfermedad por el coronavirus nCoV-2019
enfermedad por el nCoV-2019
enfermedad por el nuevo coronavirus (2019-nCoV)
enfermedad por el nuevo coronavirus de 2019
enfermedad por el virus de la COVID-19
epidemia de COVID-19
epidemia de la COVID-19
epidemia de neumonía por coronavirus de Wuhan
epidemia de neumonía por coronavirus de Wuhan de 2019-2020
epidemia de neumonía por el coronavirus de Wuhan
epidemia de neumonía por el coronavirus de Wuhan de 2019-2020
epidemia del nuevo coronavirus de 2019
epidemia por 2019-nCoV
epidemia por el 2019-nCoV
epidemia por el coronavirus de Wuhan
epidemia por el nuevo coronavirus (2019-nCoV)
epidemia por el nuevo coronavirus 2019
epidemia por el nuevo coronavirus de 2019
fiebre de neumonía por coronavirus de Wuhan
infección por 2019-nCoV
infección por coronavirus 2019-nCoV
infección por el 2019-nCoV
infección por el SARS-CoV-2
infección por el coronavirus 2019-nCoV
infección por el coronavirus de Wuhan
infección por el coronavirus del SARS de tipo 2
infección por el coronavirus del síndrome respiratorio agudo grave de tipo 2
infección por el coronavirus nCoV-2019
infección por el nCoV-2019
infección por el nuevo coronavirus (2019-nCoV)
infección por el nuevo coronavirus de 2019
infección por el virus de la COVID-19
neumonía del mercado de pescado y marisco de Wuhan
neumonía del mercado de pescados y mariscos de Wuhan
neumonía por 2019-nCoV
neumonía por coronavirus de Wuhan
neumonía por el 2019-nCoV
neumonía por el coronavirus de Wuhan
neumonía por el nuevo coronavirus (2019-nCoV)
pandemia de COVID-19
pandemia de la COVID-19
pandemia del nuevo coronavirus de 2019
pandemia por 2019-nCoV
pandemia por el coronavirus de Wuhan
pandemia por el nuevo coronavirus (2019-nCoV)
pandemia por el nuevo coronavirus 2019
pandemia por el nuevo coronavirus de 2019
pandemias de COVID-19
Scope note: Enfermedad de origen viral que suele caracterizarse por FIEBRE alta, TOS, DISNEA, ESCALOFRÍOS, TEMBLOR persistente, DOLOR MUSCULAR, CEFALEA, DOLOR DE GARGANTA, pérdida del gusto, del olfato o de ambos (véase AGEUSIA y ANOSMIA) que son de nueva aparición, así como por otros síntomas de NEUMONÍA VIRAL. En los casos graves se observan diversos síntomas asociados a coagulopatías, que a menudo guardan relación con la gravedad de la COVID-19 (p. ej., COAGULACIÓN SANGUÍNEA, TROMBOSIS, SÍNDROME DE DIFICULTAD RESPIRATORIA AGUDA, CONVULSIONES, INFARTO DE MIOCARDIO, ACCIDENTE CEREBROVASCULAR, INFARTO CEREBRAL múltiple, INSUFICIENCIA RENAL, SÍNDROME DE LOS ANTICUERPOS ANTIFOSFOLÍPIDOS muy grave y COAGULACIÓN INTRAVASCULAR DISEMINADA). En pacientes jóvenes la COVID-19 se asocia a veces a síndromes inflamatorios infrecuentes (p. ej., ENFERMEDAD DE KAWASAKI atípica, SÍNDROME DE CHOQUE TÓXICO, enfermedad inflamatoria multisistémica pediátrica y SÍNDROME DE TORMENTA DE CITOCINAS). El agente causal es un coronavirus, el SARS-CoV-2, del género BETACORONAVIRUS.
Descriptor Portuguese: COVID-19
Descriptor French: COVID-19
Entry term(s): 2019 Novel Coronavirus Disease
2019 Novel Coronavirus Epidemic
2019 Novel Coronavirus Infection
2019 Novel Coronavirus Outbreak
2019 Novel Coronavirus Pandemic
2019 Novel Coronavirus Pneumonia
2019 nCoV Disease
2019 nCoV Infection
2019-Novel Coronavirus (2019-nCoV) Infection
2019-Novel Coronavirus Pneumonia
2019-nCoV Acute Respiratory Disease
2019-nCoV Disease
2019-nCoV Diseases
2019-nCoV Epidemic
2019-nCoV Infection
2019-nCoV Infections
2019-nCoV Outbreak
2019-nCoV Pandemic
2019-nCoV Pneumonia
2019‐New Coronavirus Epidemic
2019–20 China Pneumonia Outbreak
2019–20 Wuhan Coronavirus Outbreak
COVID 19
COVID 19 Pandemic
COVID 19 Virus Disease
COVID 19 Virus Infection
COVID-19 Pandemics
COVID-19 Virus Disease
COVID-19 Virus Diseases
COVID-19 Virus Infection
COVID-19 Virus Infections
COVID-19 pandemic
COVID19
Coronavirus Disease 19
Coronavirus Disease 2019
Coronavirus Disease-19
Disease 2019, Coronavirus
Disease, 2019-nCoV
Disease, COVID-19 Virus
Infection, 2019-nCoV
Infection, COVID-19 Virus
Infection, SARS-CoV-2
Novel Coronavirus Pneumonia
Pandemic, COVID-19
SARS CoV 2 Infection
SARS Coronavirus 2 Infection
SARS-CoV-2 Infection
SARS-CoV-2 Infections
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Virus Disease, COVID-19
Virus Infection, COVID-19
Wuhan Coronavirus Epidemic
Wuhan Coronavirus Infection
Wuhan Coronavirus Outbreak
Wuhan Coronavirus Pandemic
Wuhan Coronavirus Pneumonia
Wuhan Seafood Market Pneumonia
Tree number(s): C01.748.610.763.500
C01.925.705.500
C01.925.782.600.550.200.163
C08.381.677.807.500
C08.730.610.763.500
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000086382
Scope note: A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent.
Allowable Qualifiers: BL blood
CF cerebrospinal fluid
CI chemically induced
CL classification
CN congenital
CO complications
DG diagnostic imaging
DH diet therapy
DI diagnosis
EC economics
EH ethnology
EM embryology
EN enzymology
EP epidemiology
ET etiology
GE genetics
HI history
IM immunology
ME metabolism
MI microbiology
MO mortality
NU nursing
PA pathology
PC prevention & control
PP physiopathology
PS parasitology
PX psychology
RH rehabilitation
RT radiotherapy
SU surgery
TH therapy
TM transmission
UR urine
VE veterinary
VI virology
Entry Combination: drug therapy:COVID-19 Drug Treatment
tratamento farmacológico:Tratamento Farmacológico da COVID-19
tratamiento farmacológico:Tratamiento Farmacológico de COVID-19
Public MeSH Note: 2021; for COVID-19 see under PNEUMONIA, VIRAL; CORONAVIRUS INFECTIONS; and PANDEMICS 2020
History Note: 2021(2020)
DeCS ID: 59585
Unique ID: D000086382
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2021/01/01
Date of Entry: 2020/07/07
Revision Date: 2020/06/17
COVID-19 - Preferred
Concept UI M000732426
Scope note A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent.
Preferred term COVID-19
Entry term(s) 2019 Novel Coronavirus Disease
2019 Novel Coronavirus Infection
2019 Novel Coronavirus Pneumonia
2019 nCoV Disease
2019 nCoV Infection
2019-Novel Coronavirus (2019-nCoV) Infection
2019-Novel Coronavirus Pneumonia
2019-nCoV Acute Respiratory Disease
2019-nCoV Disease
2019-nCoV Diseases
2019-nCoV Infection
2019-nCoV Infections
2019-nCoV Pneumonia
COVID 19
COVID 19 Virus Disease
COVID 19 Virus Infection
COVID-19 Virus Disease
COVID-19 Virus Diseases
COVID-19 Virus Infection
COVID-19 Virus Infections
COVID19
Coronavirus Disease 19
Coronavirus Disease 2019
Coronavirus Disease-19
Disease 2019, Coronavirus
Disease, 2019-nCoV
Disease, COVID-19 Virus
Infection, 2019-nCoV
Infection, COVID-19 Virus
Infection, SARS-CoV-2
Novel Coronavirus Pneumonia
SARS CoV 2 Infection
SARS Coronavirus 2 Infection
SARS-CoV-2 Infection
SARS-CoV-2 Infections
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Virus Disease, COVID-19
Virus Infection, COVID-19
Wuhan Coronavirus Infection
Wuhan Coronavirus Pneumonia
Wuhan Seafood Market Pneumonia
COVID-19 pandemic - Related but not broader or narrower
Concept UI M000733961
Scope note A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent.
Scope note A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent.
Preferred term COVID-19 pandemic
Entry term(s) 2019 Novel Coronavirus Epidemic
2019 Novel Coronavirus Outbreak
2019 Novel Coronavirus Pandemic
2019-nCoV Epidemic
2019-nCoV Outbreak
2019-nCoV Pandemic
2019‐New Coronavirus Epidemic
2019–20 China Pneumonia Outbreak
2019–20 Wuhan Coronavirus Outbreak
COVID 19 Pandemic
COVID-19 Pandemics
Pandemic, COVID-19
Wuhan Coronavirus Epidemic
Wuhan Coronavirus Outbreak
Wuhan Coronavirus Pandemic



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey